Paradigm Biocapital Advisors LP Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$750.1B
Holdings
27
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (27 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BIIBBIOGEN INC | 304,605 | $81.3B | 10.84% | Call |
| 2 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,175,879 | $80.1B | 10.67% | |
| 3 | MRTXEURMIRATI THERAPEUTICS INC | 850,385 | $59.4B | 7.92% | |
| 4 | INCYINCYTE CORP | 773,082 | $51.5B | 6.87% | |
| 5 | ASNDASCENDIS PHARMA A/S | 497,347 | $51.4B | 6.85% | |
| 6 | LEGNLEGEND BIOTECH CORP | 1,076,591 | $43.9B | 5.86% | |
| 7 | IMCRIMMUNOCORE HLDGS PLC | 773,079 | $36.3B | 4.84% | |
| 8 | VRDNVIRIDIAN THERAPEUTICS INC | 1,636,211 | $33.6B | 4.47% | |
| 9 | ARGXARGENX SE | 90,297 | $31.9B | 4.25% | |
| 10 | UTHUNITED THERAPEUTICS CORP DEL | 140,561 | $29.4B | 3.92% | |
| 11 | AKROAKERO THERAPEUTICS INC | 833,265 | $28.4B | 3.78% | |
| 12 | BCYCBICYCLE THERAPEUTICS PLC | 1,158,686 | $27.0B | 3.59% | |
| 13 | SNDXSYNDAX PHARMACEUTICALS INC | 1,085,142 | $26.1B | 3.48% | |
| 14 | AXSMAXSOME THERAPEUTICS INC | 520,080 | $23.2B | 3.09% | |
| 15 | HZNPHORIZON THERAPEUTICS PUB L | 351,405 | $21.7B | 2.90% | |
| 16 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,214,722 | $15.9B | 2.13% | |
| 17 | PRTAPROTHENA CORP PLC | 235,826 | $14.3B | 1.91% | |
| 18 | ARVNARVINAS INC | 283,777 | $12.6B | 1.68% | |
| 19 | ESPRESPERION THERAPEUTICS INC NE | 1,719,831 | $11.5B | 1.54% | |
| 20 | MRUSMERUS N V | 564,214 | $11.3B | 1.51% | |
| 21 | GTHXEURG1 THERAPEUTICS INC | 884,574 | $11.0B | 1.47% | |
| 22 | CRNXCRINETICS PHARMACEUTICALS IN | 519,256 | $10.2B | 1.36% | |
| 23 | OYSTOYSTER PT PHARMA INC | 1,648,316 | $9.3B | 1.23% | |
| 24 | TGTXTG THERAPEUTICS INC | 1,505,479 | $8.9B | 1.19% | |
| 25 | PSTXUSDPOSEIDA THERAPEUTICS INC | 2,070,108 | $7.3B | 0.97% | |
| 26 | VORVOR BIOPHARMA INC | 1,703,645 | $6.8B | 0.90% | |
| 27 | MISTMILESTONE PHARMACEUTICALS IN | 634,211 | $5.8B | 0.78% |